Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K243976
    Date Cleared
    2025-01-22

    (30 days)

    Product Code
    Regulation Number
    880.5440
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    ZeroClear™ Bag Access (423100)

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The ZeroClear™ Bag Access is a component of the ProSeal™ Closed System drug Transfer Device (CSTD) system. The ProSeal™ CSTD mechanically prohibits environmental contaminants from entering the system and the escape of drug or vapor concentrations from the system, thereby minimizing individual and environmental exposure to drug vapor, aerosols, and spills. The ProSeal™ system also prevents the introduction of microbial contaminations into the drug or fluid path for up to 7 days when used as intended.

    Device Description

    The ZeroClear" Bag Access is a part of the ProSeal™ Closed System drug Transfer Device (CSTD), used for injecting and infusing IV fluids and drug solutions from a standard IV bag to a patient. It features a bi-directional Luer lock connector, compatible with ISO 80369-7:2021 male Luer connectors and an ISO 8536-4:2019 compliant IV bag spike, including the applicant's eZSURE™ Empty Fluid Container (cleared K223674) and eZSURE™ Empty Fluid Container with ProSeal™ Injection Site (cleared K241442).

    This sterile, single-use device used with the appropriate connecting devices, ensures dry connections, minimizes exposure to contaminants and drug vapors, and reduces microbial ingress for up to 7 days. It is intended for use by health care professionals in clinical settings for handling hazardous drugs.

    The Subject device will be a part of a grouping of currently, twelve (12) cleared component device offerings, to the ProSeal™ CSTD system together with Epic Medical's most recently FDA cleared CSTD devices (K241988).

    AI/ML Overview

    The provided FDA 510(k) summary (K243976) for the ZeroClear™ Bag Access details the device and its intended use as a component of a Closed System Drug Transfer Device (CSTD). However, it does not contain the specific information requested regarding acceptance criteria and the comprehensive study details as outlined in the prompt (e.g., sample size for test set, expert qualifications, MRMC studies, standalone performance, ground truth establishment, training set size).

    Instead, this document focuses on demonstrating substantial equivalence to a predicate device (ProSeal™ Closed System Bag Access, K241988), primarily through functional performance, biocompatibility, and sterility testing against recognized standards. It highlights that no animal or clinical tests were deemed applicable for this submission.

    Therefore, many of the requested fields cannot be directly populated from the provided text. Based on the document, here's what can be extracted and what information is missing:

    1. Table of Acceptance Criteria and Reported Device Performance

    Acceptance CriteriaReported Device Performance (as demonstrated by conformance to standards)
    Functional Performance:
    Airtightness & water leak integrityConforms to ISO 8536-4:2019, paragraph 7.2 and Annex 3
    Tensile strengthConforms to ISO 8536-4:2019, paragraph 7.3 and Annex A.4
    Spike penetration forceConforms to ISO 22413:2021, Section 6.6, Annex A.7
    Spike protective cap integrityConforms to ISO 8536-4:2019, Section 7.13
    Vapor containmentConforms to NIOSH CSTD 2016 draft test protocol (from testing data on Subject device's NFV (LAV) connector)
    Microbial ingressConforms to FDA guidance, ANSI AAMI CN27:2021 and ISO 80369-7:2021 (from testing data on device cleared under K223674/S001)
    Particulate matterConforms to ISO 8536-4:2019 and USP
    Biocompatibility:All tests performed on devices cleared under K151650, K223674/S001, demonstrating conformance to ISO 10993 series standards.
    CytotoxicityConforms to ISO 10993-5
    SensitizationConforms to ISO 10993-10
    Intracutaneous ReactivityConforms to ISO 10993-10
    Acute Systemic ToxicityConforms to ISO 10993-11
    14-day Subacute/Subchronic Acute Systemic ToxicityConforms to ISO 10993-11 (under K223674)
    In-vitro Hemolysis AssessmentConforms to ISO 10993-4
    Material Mediated PyrogenicityConforms to ISO 10993-11
    Chemical RequirementsConforms to ISO 15747, Annex B (on device under K223674)
    Chemical Characterization and Toxicological Risk AssessmentPerformed (under K151650)
    Sterility, Shipping, & Shelf-Life:
    SterilizationConforms to ISO 11135:2014 (evaluations conducted on devices cleared under K222929)
    Simulated shippingConforms to ASTM D 4169-16
    Package integrity (Seal strength)Conforms to ASTM F88/F88M-21
    Package integrity (Dye Penetration)Conforms to ASTM F1929-23 and EN 868-5:2009
    Pyrogen TestsConforms to ANSI/AAMI ST72/2019, USP 40 , USP-NF , USP-NF (tests conducted on every lot)
    Shelf-life3 years, validated with ASTM 1980-21

    2. Sample size used for the test set and the data provenance

    • Sample Size: Not specified in the provided text for individual tests. The document mentions "testing data" but does not give specific numbers of devices or samples tested.
    • Data Provenance: The document does not explicitly state the country of origin for the data or whether the tests were retrospective or prospective. The manufacturer is Singapore-based, but testing could occur elsewhere.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts

    • This information is not applicable to the types of performance and safety tests conducted for this device (bench testing, biocompatibility, sterility). These tests do not involve expert interpretation or "ground truth" in the diagnostic or AI sense.

    4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

    • Not applicable. Adjudication methods are typically used for studies involving human interpretation or subjective assessment, which is not the case for the physical and biological tests described.

    5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, if so, what was the effect size of how much human readers improve with AI vs without AI assistance

    • Not applicable. The device is a physical medical device (component of a CSTD), not an AI-assisted diagnostic tool. No MRMC study was conducted or is relevant here.

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

    • Not applicable. The ZeroClear™ Bag Access is a physical component, not an algorithm or software. Its performance is inherent to its design and materials, not a standalone algorithmic output. The performance tests mentioned (e.g., airtightness, microbial ingress) evaluate the device itself.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.)

    • For the functional, biocompatibility, and sterility tests, the "ground truth" is defined by the pass/fail criteria of the referenced international and national standards (ISO, ANSI AAMI, ASTM, USP, NIOSH). For example, a device either leaks or it doesn't, based on predefined measurable thresholds in the standards.

    8. The sample size for the training set

    • Not applicable. There is no mention of a "training set" as this is not a machine learning or AI device.

    9. How the ground truth for the training set was established

    • Not applicable. No training set is involved.
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1